Copyright © 2012 Philip G. Ashton-Rickardt. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. G. A. Silverman, P. I. Bird, R. W. Carrell et al., “The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature,” Journal of Biological Chemistry, vol. 276, no. 36, pp. 33293–33296, 2001. View at Publisher · View at Google Scholar · View at Scopus
2. E. Remold-O'Donnell, “The ovalbumin family of serpin proteins,” FEBS Letters, vol. 315, no. 2, pp. 105–108, 1993. View at Publisher · View at Google Scholar · View at Scopus
3. R. R. Annand, J. R. Dahlen, C. A. Sprecher et al., “Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9,” Biochemical Journal, vol. 342, no. 3, pp. 655–665, 1999. View at Publisher · View at Google Scholar · View at Scopus
4. T. Komiyama, C. A. Ray, D. J. Pickup et al., “Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition,” Journal of Biological Chemistry, vol. 269, no. 30, pp. 19331–19337, 1994. View at Scopus
5. M. Tewari and V. M. Dixit, “Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product,” Journal of Biological Chemistry, vol. 270, no. 7, pp. 3255–3260, 1995. View at Publisher · View at Google Scholar · View at Scopus
6. Q. Zhou, S. Snipas, K. Ortht, M. Muzio, V. M. Dixit, and G. S. Salvesen, “Target protease specificity of the viral serpin CrmA. Analysis of five cascapses,” Journal of Biological Chemistry, vol. 272, no. 12, pp. 7797–7800, 1997. View at Publisher · View at Google Scholar · View at Scopus
7. N. Liu, S. M. Raja, F. Zazzeroni et al., “NF-κB protects from the lysosomal pathway of cell death,” EMBO Journal, vol. 22, no. 19, pp. 5313–5322, 2003. View at Publisher · View at Google Scholar · View at Scopus
8. M. Al-Khunaizi, C. J. Luke, Y. S. Askew et al., “The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases,” Biochemistry, vol. 41, no. 9, pp. 3189–3199, 2002. View at Publisher · View at Google Scholar · View at Scopus
9. C. Schick, P. A. Pemberton, G. P. Shi et al., “Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis,” Biochemistry, vol. 37, no. 15, pp. 5258–5266, 1998. View at Publisher · View at Google Scholar · View at Scopus
10. C. J. Luke, S. C. Pak, Y. S. Askew et al., “An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury,” Cell, vol. 130, no. 6, pp. 1108–1119, 2007. View at Publisher · View at Google Scholar · View at Scopus
11. Q. L. Deveraux, N. Roy, H. R. Stennicke et al., “IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases,” EMBO Journal, vol. 17, no. 8, pp. 2215–2223, 1998. View at Publisher · View at Google Scholar · View at Scopus
12. V. Turk and W. Bode, “The cystatins: protein inhibitors of cysteine proteinases,” FEBS Letters, vol. 285, no. 2, pp. 213–219, 1991. View at Publisher · View at Google Scholar · View at Scopus
13. M. Leist and M. Jaattela, “Four deaths and a funeral: from caspases to alternative mechanisms,” Nature Reviews Molecular Cell Biology, vol. 2, no. 8, pp. 589–598, 2001. View at Publisher · View at Google Scholar · View at Scopus
14. K. F. Ferri and G. Kroemer, “Organelle-specific initiation of cell death pathways,” Nature Cell Biology, vol. 3, no. 11, pp. E255–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
15. K. Schulze-Osthoff, A. C. Bakker, B. Vanhaesebroeck, R. Beyaert, W. A. Jacob, and W. Fiers, “Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation,” Journal of Biological Chemistry, vol. 267, no. 8, pp. 5317–5323, 1992. View at Scopus
16. D. Vercammen, R. Beyaert, G. Denecker et al., “Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor,” Journal of Experimental Medicine, vol. 187, no. 9, pp. 1477–1485, 1998. View at Publisher · View at Google Scholar · View at Scopus
17. D. Vercammen, G. Brouckaert, G. Denecker et al., “Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways,” Journal of Experimental Medicine, vol. 188, no. 5, pp. 919–930, 1998. View at Publisher · View at Google Scholar · View at Scopus
18. H. C. Ha and S. H. Snyder, “Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 24, pp. 13978–13982, 1999. View at Publisher · View at Google Scholar · View at Scopus
19. A. M. Tolkovsky, L. Xue, G. C. Fletcher, and V. Borutaite, “Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease?” Biochimie, vol. 84, no. 2-3, pp. 233–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
20. G. Denecker, D. Vercammen, M. Steemans et al., “Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria,” Cell Death and Differentiation, vol. 8, no. 8, pp. 829–840, 2001. View at Publisher · View at Google Scholar · View at Scopus
21. J. Lieberman, “The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal,” Nature Reviews Immunology, vol. 3, no. 5, pp. 361–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
22. M. Jaattela and J. Tschopp, “Caspase-independent cell death in T lymphocytes,” Nature Immunology, vol. 4, no. 5, pp. 416–423, 2003. View at Publisher · View at Google Scholar · View at Scopus
23. C. E. Chwieralski, T. Welte, and F. Bühling, “Cathepsin-regulated apoptosis,” Apoptosis, vol. 11, no. 2, pp. 143–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
24. M. E. Guicciardi, J. Deussing, H. Miyoshi et al., “Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c,” Journal of Clinical Investigation, vol. 106, no. 9, pp. 1127–1137, 2000. View at Scopus
25. M. Van Eijk and C. De Groot, “Germinal center B cell apoptosis requires both caspase and cathepsin activity,” Journal of Immunology, vol. 163, no. 5, pp. 2478–2482, 1999. View at Scopus
26. M. C. Michallet, F. Saltel, M. Flacher, J. P. Revillard, and L. Genestier, “Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: a possible mechanism of high dose tolerance,” Journal of Immunology, vol. 172, no. 9, pp. 5405–5414, 2004. View at Scopus
27. X. M. Yuan, W. Li, H. Dalen et al., “Lysosomal destabilization in p53-induced apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 9, pp. 6286–6291, 2002. View at Publisher · View at Google Scholar · View at Scopus
28. K. Roberg and K. Öllinger, “Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes,” American Journal of Pathology, vol. 152, no. 5, pp. 1151–1156, 1998. View at Scopus
29. K. Roberg, K. Kågedal, and K. Öllinger, “Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts,” American Journal of Pathology, vol. 161, no. 1, pp. 89–96, 2002. View at Scopus
30. L. Foghsgaard, D. Wissing, D. Mauch et al., “Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor,” Journal of Cell Biology, vol. 153, no. 5, pp. 999–1009, 2001. View at Publisher · View at Google Scholar · View at Scopus
31. E. Katz, M. R. Deehan, S. Seatter, C. Lord, R. D. Sturrock, and M. M. Harnett, “B cell receptor-stimulated mitochondrial phospholipase A2 activation and resultant disruption of mitochondrial membrane potential correlate with the induction of apoptosis in WEHI-231 B cells,” Journal of Immunology, vol. 166, no. 1, pp. 137–147, 2001. View at Scopus
32. J. Sun, C. H. Bird, V. Sutton et al., “A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes,” Journal of Biological Chemistry, vol. 271, no. 44, pp. 27802–27809, 1996. View at Publisher · View at Google Scholar · View at Scopus
33. J. Sun, L. Ooms, C. H. Bird, V. R. Sutton, J. A. Trapani, and P. I. Bird, “A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9),” Journal of Biological Chemistry, vol. 272, no. 24, pp. 15434–15441, 1997. View at Publisher · View at Google Scholar · View at Scopus
34. N. Liu, Y. Wang, and P. G. Ashton-Rickardt, “Serine protease inhibitor 2A inhibits caspase-independent cell death,” FEBS Letters, vol. 569, no. 1–3, pp. 49–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
35. L. Hampson, I. N. Hampson, C. K. Babichuk et al., “A minimal serpin promoter with high activity in haematopoietic progenitors and activated T cells,” Hematology Journal, vol. 2, no. 3, pp. 150–160, 2001. View at Publisher · View at Google Scholar · View at Scopus
36. R. H. Schwartz, “Acquisition of immunologic self-tolerance,” Cell, vol. 57, no. 7, pp. 1073–1081, 1989. View at Scopus
37. D. Lo and J. Sprent, “Identity of cells that imprint H-2-restricted T-cell specificity in the thymus,” Nature, vol. 319, no. 6055, pp. 672–675, 1986. View at Scopus
38. P. Kisielow, H. S. Teh, H. Bluthmann, and H. Von Boehmer, “Positive selection of antigen-specific T cells in thymus by restricting MHC molecules,” Nature, vol. 335, no. 6192, pp. 730–733, 1988. View at Scopus
39. B. Scott, H. Bluthmann, H. S. Teh, and H. Von Boehmer, “The generation of mature T cells requires interaction of the αβ T-cell receptor with major histocompatibility antigens,” Nature, vol. 338, no. 6216, pp. 591–593, 1989. View at Scopus
40. H. S. Teh, P. Kisielow, B. Scott et al., “Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells,” Nature, vol. 335, no. 6187, pp. 229–233, 1988. View at Scopus
41. J. Zerrahn, W. Held, and D. H. Raulet, “The MHC reactivity of the T cell repertoire prior to positive and negative selection,” Cell, vol. 88, no. 5, pp. 627–636, 1997. View at Publisher · View at Google Scholar · View at Scopus
42. P. G. Ashton-Rickardt, “A license to remember,” Nature Immunology, vol. 5, no. 11, pp. 1097–1098, 2004. View at Publisher · View at Google Scholar · View at Scopus
43. H. Dooms and A. K. Abbas, “Control of CD4+ T-cell memory by cytokines and costimulators,” Immunological Reviews, vol. 211, pp. 23–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
44. J. H. Russell and T. J. Ley, “Lymphocyte-mediated cytotoxicity,” Annual Review of Immunology, vol. 20, pp. 323–370, 2002. View at Publisher · View at Google Scholar
45. L. L. Lau, B. D. Jamieson, T. Somasundaram, and R. Ahmed, “Cytotoxic T-cell memory without antigen,” Nature, vol. 369, no. 6482, pp. 648–652, 1994. View at Publisher · View at Google Scholar · View at Scopus
46. K. Murali-Krishna, J. D. Altman, M. Suresh et al., “Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection,” Immunity, vol. 8, no. 2, pp. 177–187, 1998. View at Publisher · View at Google Scholar · View at Scopus
47. R. Ahmed and D. Gray, “Immunological memory and protective immunity: understanding their relation,” Science, vol. 272, no. 5258, pp. 54–60, 1996. View at Scopus
48. H. Hu, G. Huston, D. Duso, N. Lepak, E. Roman, and S. L. Swain, “CD4+ T cell effectors can become memory cells with high efficiency and without further division,” Nature Immunology, vol. 2, no. 8, pp. 705–710, 2001. View at Publisher · View at Google Scholar · View at Scopus
49. M. Löhning, A. N. Hegazy, D. D. Pinschewer et al., “Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors,” Journal of Experimental Medicine, vol. 205, no. 1, pp. 53–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
50. J. T. Opferman, B. T. Ober, and P. G. Ashton-Rickardt, “Linear differentiation of cytotoxic effectors into memory T lymphocytes,” Science, vol. 283, no. 5408, pp. 1745–1748, 1999. View at Publisher · View at Google Scholar · View at Scopus
51. T. C. Becker, S. M. Coley, E. J. Wherry, and R. Ahmed, “Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells,” Journal of Immunology, vol. 174, no. 3, pp. 1269–1273, 2005. View at Scopus
52. G. Cassese, E. Parretta, L. Pisapia, A. Santoni, J. Guardiola, and F. Di Rosa, “Bone marrow CD8 cells down-modulate membrane IL-7Rα expression and exhibit increased STAT-5 and p38 MAPK phosphorylation in the organ environment,” Blood, vol. 110, no. 6, pp. 1960–1969, 2007. View at Publisher · View at Google Scholar · View at Scopus
53. I. B. Mazo, M. Honczarenko, H. Leung et al., “Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells,” Immunity, vol. 22, no. 2, pp. 259–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
54. D. Hildeman, T. Jorgensen, J. Kappler, and P. Marrack, “Apoptosis and the homeostatic control of immune responses,” Current Opinion in Immunology, vol. 19, no. 5, pp. 516–521, 2007. View at Publisher · View at Google Scholar · View at Scopus
55. J. T. Opferman, A. Letai, C. Beard, M. D. Sorcinelli, C. C. Ong, and S. J. Korsmeyer, “Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1,” Nature, vol. 426, no. 6967, pp. 671–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
56. P. J. Millard, M. P. Henkart, C. W. Reynolds, and P. A. Henkart, “Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors,” Journal of Immunology, vol. 132, no. 6, pp. 3197–3204, 1984. View at Scopus
57. E. R. Podack, J. D. E. Young, and Z. A. Cohn, “Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 24, pp. 8629–8633, 1985. View at Scopus
58. D. Kagi, B. Ledermann, K. Burki et al., “Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice,” Nature, vol. 369, no. 6475, pp. 31–37, 1994. View at Publisher · View at Google Scholar · View at Scopus
59. L. Shi, C. M. Kam, J. C. Powers, R. Aebersold, and A. H. Greenberg, “Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions,” Journal of Experimental Medicine, vol. 176, no. 6, pp. 1521–1530, 1992. View at Publisher · View at Google Scholar · View at Scopus
60. D. Kagi, F. Vignaux, B. Ledermann et al., “Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity,” Science, vol. 265, no. 5171, pp. 528–530, 1994. View at Scopus
61. A. Kupfer, S. J. Singer, and G. Dennert, “On the mechanism of unidirectional killing in mixtures of two cytotoxic T lymphocytes. Unidirectional polarization of cytoplasmic organelles and the membrane-associated cytoskeleton in the effector cell,” Journal of Experimental Medicine, vol. 163, no. 3, pp. 489–498, 1986. View at Scopus
62. T. A. Lyubchenko, G. A. Wurth, and A. Zweifach, “Role of calcium influx in cytotoxic T lymphocyte lytic granule exocytosis during target cell killing,” Immunity, vol. 15, no. 5, pp. 847–859, 2001. View at Publisher · View at Google Scholar · View at Scopus
63. J. C. Stinchcombe, G. Bossi, S. Booth, and G. M. Griffiths, “The immunological synapse of CTL contains a secretory domain and membrane bridges,” Immunity, vol. 15, no. 5, pp. 751–761, 2001. View at Publisher · View at Google Scholar · View at Scopus
64. C. J. Froelich, K. Orth, J. Turbov et al., “New paradigm for lymphocyte granule-mediated cytotoxicity: target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis,” Journal of Biological Chemistry, vol. 271, no. 46, pp. 29073–29079, 1996. View at Publisher · View at Google Scholar · View at Scopus
65. J. A. Trapani, K. A. Browne, M. J. Smyth, and D. A. Jans, “Localization of granzyme B in the nucleus: a putative role in the mechanism of cytotoxic lymphocyte-mediated apoptosis,” Journal of Biological Chemistry, vol. 271, no. 8, pp. 4127–4133, 1996. View at Scopus
66. S. Odake, C. M. Kam, L. Narasimhan et al., “Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins,” Biochemistry, vol. 30, no. 8, pp. 2217–2227, 1991. View at Scopus
67. D. Spaner, K. Raju, L. Radvanyi, Y. Lin, and R. G. Miller, “A role for perforin in activation-induced cell death,” Journal of Immunology, vol. 160, no. 6, pp. 2655–2664, 1998. View at Scopus
68. J. T. Opferman, B. T. Ober, R. Narayanan, and P. G. Ashton-Rickardt, “Suicide induced by cytolytic activity controls the differentiation of memory CD8+ T lymphocytes,” International Immunology, vol. 13, no. 4, pp. 411–419, 2001. View at Scopus
69. D. Spaner, K. Raju, B. Rabinovich, and R. G. Miller, “A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice,” Journal of Immunology, vol. 162, no. 2, pp. 1192–1199, 1999. View at Scopus
70. D. Kagi, B. Odermatt, and T. W. Mak, “Homeostatic regulation of CD8+ T cells by perforin,” European Journal of Immunology, vol. 29, no. 10, pp. 3262–3272, 1999. View at Publisher · View at Google Scholar
71. M. Matloubian, M. Suresh, A. Glass et al., “A role for perforin in downregulating T-cell responses during chronic viral infection,” Journal of Virology, vol. 73, no. 3, pp. 2527–2536, 1999. View at Scopus
72. V. P. Badovinac, A. R. Tvinnereim, and J. T. Harty, “Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-γ,” Science, vol. 290, no. 5495, pp. 1354–1357, 2000. View at Publisher · View at Google Scholar · View at Scopus
73. V. P. Badovinac, S. E. Hamilton, and J. T. Harty, “Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice,” Immunity, vol. 18, no. 4, pp. 463–474, 2003. View at Publisher · View at Google Scholar · View at Scopus
74. S. E. Stepp, P. A. Mathew, M. Bennett, G. De Saint Basile, and V. Kumar, “Perforin: more than just an effector molecule,” Immunology Today, vol. 21, no. 6, pp. 254–256, 2000. View at Publisher · View at Google Scholar · View at Scopus
75. S. E. Stepp, R. Dufourcq-Lagelouse, F. Le Deist et al., “Perforin gene defects in familial hemophagocytic lymphohistiocytosis,” Science, vol. 286, no. 5446, pp. 1957–1959, 1999. View at Publisher · View at Google Scholar · View at Scopus
76. P. R. Walden and H. N. Eisen, “Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 22, pp. 9015–9019, 1990. View at Publisher · View at Google Scholar · View at Scopus
77. E. Hanon, J. C. Stinchcombe, M. Saito et al., “Fracticide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I,” Immunity, vol. 13, no. 5, pp. 657–664, 2000. View at Scopus
78. J. F. Huang, Y. Yang, H. Sepulveda et al., “TCR-mediated internalization of peptide-MHC complexes acquired by T cells,” Science, vol. 286, no. 5441, pp. 952–954, 1999. View at Publisher · View at Google Scholar · View at Scopus
79. L. Chen, M. Woo, R. Hakem, and R. G. Miller, “Perforin-dependent activation-induced cell death acts through caspase 3 but not through caspases 8 or 9,” European Journal of Immunology, vol. 33, no. 3, pp. 769–778, 2003. View at Publisher · View at Google Scholar · View at Scopus
80. S. Isaaz, K. Baetz, K. Olsen, E. Podack, and G. M. Griffiths, “Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway,” European Journal of Immunology, vol. 25, no. 4, pp. 1071–1079, 1995. View at Scopus
81. H. Ida, T. Nakashima, N. L. Kedersha et al., “Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death,” European Journal of Immunology, vol. 33, no. 12, pp. 3284–3292, 2003. View at Publisher · View at Google Scholar · View at Scopus
82. C. E. Hirst, M. S. Buzza, C. H. Bird et al., “The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency,” Journal of Immunology, vol. 170, no. 2, pp. 805–815, 2003. View at Scopus
83. T. Phillips, J. T. Opferman, R. Shah, N. Liu, C. J. Froelich, and P. G. Ashton-Rickardt, “A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8 + memory cell homeostasis,” Journal of Immunology, vol. 173, no. 6, pp. 3801–3809, 2004. View at Scopus
84. M. Zhang, S. M. Park, Y. Wang et al., “Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules,” Immunity, vol. 24, no. 4, pp. 451–461, 2006. View at Publisher · View at Google Scholar · View at Scopus
85. M. Zhang, S. Byrne, N. Liu, Y. Wang, A. Oxenius, and P. G. Ashton-Rickardt, “Differential survival of cytotoxic T cells and memory cell precursors,” Journal of Immunology, vol. 178, no. 6, pp. 3483–3491, 2007. View at Scopus
86. M. A. Cannarile, N. A. Lind, R. Rivera et al., “Transcriptional regulator Id2 mediates CD8+ T cell immunity,” Nature Immunology, vol. 7, no. 12, pp. 1317–1325, 2006. View at Publisher · View at Google Scholar · View at Scopus
87. D. I. Godfrey, H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer, “NKT cells: what's in a name?” Nature Reviews Immunology, vol. 4, no. 3, pp. 231–237, 2004. View at Scopus
88. A. Bendelac, P. B. Savage, and L. Teyton, “The biology of NKT cells,” Annual Review of Immunology, vol. 25, pp. 297–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
89. A. W. Ansari, J. N. Temblay, S. H. Alyahya, and P. G. Ashton-Rickardt, “Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage,” Journal of Immunology, vol. 185, no. 2, pp. 877–883, 2010. View at Publisher · View at Google Scholar · View at Scopus
90. J. Jacob and D. Baltimore, “Modelling T-cell memory by genetic marking of memory T cells in vivo,” Nature, vol. 399, no. 6736, pp. 593–597, 1999. View at Publisher · View at Google Scholar · View at Scopus
91. S. M. Kaech, S. Hemby, E. Kersh, and R. Ahmed, “Molecular and functional profiling of memory CD8 T cell differentiation,” Cell, vol. 111, no. 6, pp. 837–851, 2002. View at Publisher · View at Google Scholar · View at Scopus
92. N. Liu, T. Phillips, M. Zhang et al., “Serine protease inhibitor 2A is a protective factor for memory T cell development,” Nature Immunology, vol. 5, no. 9, pp. 919–926, 2004. View at Publisher · View at Google Scholar · View at Scopus
93. S. Forsyth, A. Horvath, and P. Coughlin, “A review and comparison of the murine α1-antitrypsin and α1-antichymotrypsin multigene clusters with the human clade A serpins,” Genomics, vol. 81, no. 3, pp. 336–345, 2003. View at Publisher · View at Google Scholar · View at Scopus
94. S. M. Byrne, A. Aucher, S. H. Alyahya et al., “Cathepsin B controls the persistence of memory CD8+ T cells,” Journal of Immunology, vol. 189, no. 3, pp. 1133–1143, 2012. View at Publisher · View at Google Scholar
95. N. S. Joshi, W. Cui, A. Chandele et al., “Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor,” Immunity, vol. 27, no. 2, pp. 281–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
96. S. Jung, D. Unutmaz, P. Wong et al., “In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens,” Immunity, vol. 17, no. 2, pp. 211–220, 2002. View at Publisher · View at Google Scholar · View at Scopus
97. D. J. Zammit, L. S. Cauley, Q. M. Pham, and L. Lefrançois, “Dendritic cells maximize the memory CD8 T cell response to infection,” Immunity, vol. 22, no. 5, pp. 561–570, 2005. View at Publisher · View at Google Scholar · View at Scopus
98. G. T. Belz, C. M. Smith, D. Eichner et al., “Cutting edge: conventional CD8α+ dendritic cells are generally involved in priming CTL immunity to viruses,” Journal of Immunology, vol. 172, no. 4, pp. 1996–2000, 2004. View at Scopus
99. W. R. Heath, G. T. Belz, G. M. N. Behrens et al., “Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens,” Immunological Reviews, vol. 199, pp. 9–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
100. I. F. Hermans, D. S. Ritchie, J. Yang, J. M. Roberts, and F. Ronchese, “CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity,” Journal of Immunology, vol. 164, no. 6, pp. 3095–3101, 2000. View at Scopus
101. J. Yang, S. P. Huck, R. S. McHugh, I. F. Hermans, and F. Ronchese, “Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 1, pp. 147–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
102. L. M. Wakim, J. Waithman, N. Van Rooijen, W. R. Heath, and F. R. Carbone, “Dendritic cell-induced memory T cell activation in nonlymphoid tissues,” Science, vol. 319, no. 5860, pp. 198–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
103. P. Wong and E. G. Pamer, “Feedback regulation of pathogen-specific T cell priming,” Immunity, vol. 18, no. 4, pp. 499–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
104. J. P. Medema, J. De Jong, L. T. C. Peltenburg et al., “Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11515–11520, 2001. View at Publisher · View at Google Scholar · View at Scopus
105. E. Lovo, M. Zhang, L. Wang, and P. G. Ashton-Rickardt, “Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death,” Journal of Immunology, vol. 188, no. 3, pp. 1057–1063, 2012.
106. T. A. Graubert, J. F. DiPersio, J. H. Russell, and T. J. Ley, “Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation,” Journal of Clinical Investigation, vol. 100, no. 4, pp. 904–911, 1997. View at Scopus
107. Y. Miura, C. J. Thoburn, E. C. Bright, and A. D. Hess, “Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand,” Biology of Blood and Marrow Transplantation, vol. 10, no. 3, pp. 156–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
108. R. Goldbach-Mansky, S. Suson, R. Wesley, C. E. Hack, H. S. El-Gabalawy, and P. P. Tak, “Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthrits,” Annals of the Rheumatic Diseases, vol. 64, no. 5, pp. 715–721, 2005. View at Publisher · View at Google Scholar · View at Scopus
109. M. C. Kraan, J. J. Haringman, H. Weedon et al., “T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 63, no. 5, pp. 483–488, 2004. View at Publisher · View at Google Scholar · View at Scopus
110. J. C. Choy, R. P. Cruz, A. Kerjner et al., “Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease,” American Journal of Transplantation, vol. 5, no. 3, pp. 494–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
111. J. C. Choy, P. C. McDonald, A. C. Suarez et al., “Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity,” Modern Pathology, vol. 16, no. 5, pp. 460–470, 2003. View at Publisher · View at Google Scholar · View at Scopus
112. D. Jenkins, R. Seth, J. A. Kummer, B. B. Scott, C. J. Hawkey, and R. A. Robins, “Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation,” Journal of Pathology, vol. 190, no. 2, pp. 184–189, 2000. View at Publisher · View at Google Scholar
113. C. G. Bien, J. Bauer, T. L. Deckwerth et al., “Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis,” Annals of Neurology, vol. 51, no. 3, pp. 311–318, 2002. View at Publisher · View at Google Scholar · View at Scopus
114. P. Blanco, V. Pitard, J. F. Viallard, J. L. Taupin, J. L. Pellegrin, and J. F. Moreau, “Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 52, no. 1, pp. 201–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
115. B. A. Bladergroen, M. C. M. Strik, A. M. Wolbink et al., “The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells,” European Journal of Immunology, vol. 35, no. 4, pp. 1175–1183, 2005. View at Publisher · View at Google Scholar · View at Scopus
116. B. A. Bladergroen, M. C. M. Strik, N. Bovenschen et al., “The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites,” Journal of Immunology, vol. 166, no. 5, pp. 3218–3225, 2001. View at Scopus
117. J. L. Young, G. K. Sukhova, D. Foster, W. Kisiel, P. Libby, and U. Schönbeck, “The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1β-converting enzyme (caspase-1) activity in human vascular smooth muscle cells,” Journal of Experimental Medicine, vol. 191, no. 9, pp. 1535–1544, 2000. View at Publisher · View at Google Scholar · View at Scopus
118. L. T. Quan, A. Caputo, R. C. Bleackley, D. J. Pickup, and G. S. Salvesen, “Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A,” Journal of Biological Chemistry, vol. 270, no. 18, pp. 10377–10379, 1995. View at Publisher · View at Google Scholar · View at Scopus
119. J. L. Macen, R. S. Garner, P. Y. Musy et al., “Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 17, pp. 9108–9113, 1996. View at Publisher · View at Google Scholar · View at Scopus
120. B. A. Bladergroen, C. J. L. M. Meijer, R. L. Ten Berge et al., “Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?” Blood, vol. 99, no. 1, pp. 232–237, 2002. View at Publisher · View at Google Scholar · View at Scopus
121. R. L. Ten Berge, C. J. L. M. Meijer, D. F. Dukers et al., “Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma,” Blood, vol. 99, no. 12, pp. 4540–4546, 2002. View at Publisher · View at Google Scholar · View at Scopus
122. J. W. Fisher, S. Koury, T. Ducey, and S. Mendel, “Erythropoietin production by interstitial cells of hypoxic monkey kidneys,” British Journal of Haematology, vol. 95, no. 1, pp. 27–32, 1996. View at Scopus
123. D. M. Wojchowski, P. Sathyanarayana, and A. Dev, “Erythropoietin receptor response circuits,” Current Opinion in Hematology, vol. 17, no. 3, pp. 169–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
124. H. Wu, X. Liu, R. Jaenisch, and H. F. Lodish, “Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor,” Cell, vol. 83, no. 1, pp. 59–67, 1995. View at Scopus
125. A. C. Johansson, H. Appelqvist, C. Nilsson, K. Kågedal, K. Roberg, and K. Öllinger, “Regulation of apoptosis-associated lysosomal membrane permeabilization,” Apoptosis, vol. 15, no. 5, pp. 527–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
126. R. Blomgran, L. Zheng, and O. Stendahl, “Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization,” Journal of Leukocyte Biology, vol. 81, no. 5, pp. 1213–1223, 2007. View at Publisher · View at Google Scholar · View at Scopus
127. E. Fibach and E. A. Rachmilewitz, “The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia,” Annals of the New York Academy of Sciences, vol. 1202, pp. 10–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
128. C. J. Luckey, D. Bhattacharya, A. W. Goldrath, I. L. Weissman, C. Benoist, and D. Mathis, “Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 9, pp. 3304–3309, 2006. View at Publisher · View at Google Scholar · View at Scopus
129. J. P. Medema, D. H. Schuurhuis, D. Rea et al., “Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells,” Journal of Experimental Medicine, vol. 194, no. 5, pp. 657–667, 2001. View at Publisher · View at Google Scholar · View at Scopus
130. D. E. Hassett, M. K. Slifka, J. Zhang, and J. L. Whitton, “Direct ex vivo kinetic and phenotypic analyses of CD8+ T-cell responses induced by DNA immunization,” Journal of Virology, vol. 74, no. 18, pp. 8286–8291, 2000. View at Publisher · View at Google Scholar · View at Scopus
131. J. Rice, M. L. Dossett, C. Öhlén et al., “DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire,” European Journal of Immunology, vol. 38, no. 8, pp. 2118–2130, 2008. View at Publisher · View at Google Scholar · View at Scopus
132. J. N. Radcliffe, J. S. Roddick, F. K. Stevenson, and S. M. Thirdborough, “Prolonged antigen expression following DNA vaccination impairs effector CD8+ T cell function and memory development,” Journal of Immunology, vol. 179, no. 12, pp. 8313–8321, 2007. View at Scopus
133. T. W. Kim, C. F. Hung, D. A. K. Boyd et al., “Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6,” Cancer Research, vol. 64, no. 1, pp. 400–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
134. N. El Haddad, D. Heathcote, R. Moore et al., “Mesenchymal stem cells express serine protease inhibitor to evade the host immune response,” Blood, vol. 117, no. 4, pp. 1176–1183, 2011. View at Publisher · View at Google Scholar · View at Scopus
135. N. El Haddad, R. Moore, D. Heathcote et al., “The novel role of SERPINB9 in cytotoxic protection of human mesenchymal stem cells,” Journal of Immunology, vol. 187, no. 5, pp. 2252–2260, 2011. View at Publisher · View at Google Scholar
136. C. G. Bien, G. Widman, H. Urbach et al., “The natural history of Rasmussen's encephalitis,” Brain, vol. 125, no. 8, pp. 1751–1759, 2002. View at Scopus
137. A. T. Rowshani, S. Florquin, F. Bemelman, J. A. Kummer, C. E. Hack, and I. J. M. Ten Berge, “Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection,” Kidney International, vol. 66, no. 4, pp. 1417–1422, 2004. View at Publisher · View at Google Scholar · View at Scopus
138. L. Del Vecchio, A. Cavalli, B. Tucci, and F. Locatelli, “Chronic kidney disease-associated anemia: new remedies,” Current Opinion in Investigational Drugs, vol. 11, no. 9, pp. 1030–1038, 2010. View at Scopus
139. M. Dicato and L. Plawny, “Erythropoietin in cancer patients: pros and cons,” Current Opinion in Oncology, vol. 22, no. 4, pp. 307–311, 2010. View at Publisher · View at Google Scholar · View at Scopus
140. D. J. Buttle, M. Murata, C. G. Knight, and A. J. Barrett, “CA074 methyl ester: a proinhibitor for intracellular cathepsin B,” Archives of Biochemistry and Biophysics, vol. 299, no. 2, pp. 377–380, 1992. View at Publisher · View at Google Scholar · View at Scopus
141. J. L. Spivak, P. Gascón, and H. Ludwig, “Anemia management in oncology and hematology,” The Oncologist, vol. 14, supplement 1, pp. 43–56, 2009. View at Scopus
142. H. Schmid and H. Schiffl, “Erythropoiesis stimulating agents and anaemia of end-stage renal disease,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 8, no. 3, pp. 164–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
143. T. Willinger, T. Freeman, H. Hasegawa, A. J. McMichael, and M. F. C. Callan, “Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets,” Journal of Immunology, vol. 175, no. 9, pp. 5895–5903, 2005. View at Scopus
144. S. Halfon, J. Ford, J. Foster et al., “Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells,” Journal of Biological Chemistry, vol. 273, no. 26, pp. 16400–16408, 1998. View at Publisher · View at Google Scholar · View at Scopus
145. C. A. Willoughby, H. G. Bull, M. Garcia-Calvo, J. Jiang, K. T. Chapman, and N. A. Thornberry, “Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis,” Bioorganic and Medicinal Chemistry Letters, vol. 12, no. 16, pp. 2197–2200, 2002. View at Publisher · View at Google Scholar · View at Scopus